L. Sánchez-Bilbao

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients

L. Sánchez-Bilbao, D. Martínez-López, Marcelino Revenga et al. · Journal of Clinical Medicine · 2020 · 88 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients

L Domínguez-Casas, L. Sánchez-Bilbao, V. Calvo-Río et al. · Seminars in Arthritis and Rheumatism · 2020 · 43 citations

Medicine, Dermatology, Ophthalmology +10

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review

Belén Atienza‐Mateo, Sara Remuzgo‐Martínez, D. Prieto-Peña et al. · Journal of Clinical Medicine · 2020 · 32 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

J. Loricera, Santos Castañeda, C. Moriano et al. · Therapeutic Advances in Musculoskeletal Disease · 2022 · 26 citations · Full text

Medicine, Neurology, Ophthalmology +10

Systemic treatment in sarcoidosis: Experience over two decades

R. Fernández-Ramón, J. J. Gaitán-Valdizán, I. González-Mazón et al. · European Journal of Internal Medicine · 2022 · 25 citations

Life Sciences, Internal Medicine, Pharmacotherapy +5